The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Byotrol Plc

6 Sep 2017 11:37

RNS Number : 9681P
Maven Capital Partners
06 September 2017
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Maven Capital Partners UK LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC, Maven Income and Growth VCT 6 PLC

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Byotrol Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

05/09/17

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

14,483,562

3.6

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

14,483,562

3.6

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

06 September 2017

Contact name:

Graeme Cullen

Telephone number:

0141 206 0110

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETOKADQCBKKNCK
Date   Source Headline
3rd May 20137:00 amRNSDirector/PDMR Shareholding
30th Apr 20134:55 pmRNSIssue of Equity
30th Apr 20134:47 pmRNSNet Asset Value(s)
30th Apr 20134:44 pmRNSAnnual Financial Report
8th Apr 201311:29 amRNSIssue of Equity
5th Apr 20134:21 pmRNSNAV and updated subscription price
3rd Apr 20131:54 pmRNSMerger Results
26th Mar 20132:04 pmRNSRestults of General Meeting and Class Meetings
4th Mar 20136:08 pmRNSFurther re merger offer
4th Mar 20134:49 pmRNSFurther re merger and offer
4th Mar 20134:47 pmRNSFurther re merger and Offer
4th Mar 20137:00 amRNSDoc re posting of proposed merger documents
4th Mar 20137:00 amRNSAnnouncement re: posting of merger documents
1st Mar 201311:49 amRNSDividend Declaration and unaudited NAV
1st Mar 20137:00 amRNSDividend Declaration
13th Feb 201312:11 pmRNSMerger Update
9th Nov 20125:01 pmRNSInterim Management Statement
31st Oct 20125:03 pmRNSHalf Yearly Report
31st Oct 20124:25 pmRNSDoc re. Joint Announcement of Potential Merger
31st Oct 20124:25 pmRNSDoc re. Joint Announcement of Potential Merger
28th Aug 20125:24 pmRNSHalf Yearly Report
12th Jul 20125:01 pmRNSAnnual Information Update
17th May 20121:02 pmRNSResult of AGM
17th May 20129:31 amRNSInterim Management Statement
3rd May 20125:36 pmRNSTransaction in Own Shares
2nd May 20124:12 pmRNSDirector/PDMR Shareholding
2nd May 20123:59 pmRNSDirector/PDMR Shareholding
2nd May 20123:30 pmRNSTransaction in Own Shares
26th Apr 20122:24 pmRNSTransaction in Own Shares
20th Apr 20121:11 pmRNSIssue of Equity
18th Apr 201212:26 pmRNSAnnual Financial Report - Replacement
17th Apr 20124:40 pmRNSAnnual Financial Report
10th Apr 20129:59 amRNSIssue of Equity
8th Mar 20124:02 pmRNSDirector/PDMR Shareholding
2nd Mar 20129:39 amRNSIssue of Equity
7th Dec 20114:20 pmRNSIssue of Equity
22nd Nov 20114:45 pmRNSTransaction in Own Shares
17th Nov 20114:55 pmRNSTransaction in Own Shares
16th Nov 20113:09 pmRNSInterim Management Statement
29th Sep 20115:04 pmRNSTransaction in Own Shares
15th Aug 20113:34 pmRNSHalf Yearly Report
1st Jul 20117:00 amRNSTransaction in Own Shares
29th Jun 20112:44 pmRNSTransaction in Own Shares
29th Jun 20112:43 pmRNSTransaction in Own Shares
14th Jun 201110:51 amRNSStatement re cancellation of share premium
24th May 20113:27 pmRNSAnnual Information Update
20th May 20114:16 pmRNSInterim Management Statement
12th May 201111:08 amRNSResult of AGM
4th May 20113:26 pmRNSIssue of Equity
14th Apr 20116:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.